Home > Quotes > GILD
GILD

Gilead Sciences, Inc. Common Stock Quote & Summary Data

$88.21
*  
8.79
9.06%
Get GILD Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Gilead Sciences, Inc. Common Stock Intraday Chart




News for GILD

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 92.53 $ 123.37
Low $ 87.80 $ 81.89

The current last sale of $88.21 is 7.72% Higher thanthe 52 week low.

P/E Ratio

ETFs with GILD as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
8.06% iShares Nasdaq Biotechnology Index Fund (IBB) -63.77 (-19.22%)
5.28% PowerShares Dynamic Biotech &Genome (PBE) -10.97 (-21.81%)
5.21% SPDR Select Sector Fund - Health Care (XLV) -1.99 (-2.77%)
4.92% iShares U.S. Healthcare ETF (IYH) -6.28 (-4.16%)
4.81% Vanguard Health Care ETF - DNQ (VHT) -5.47 (-4.13%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Gilead Sciences, Inc. (Gilead, we or us), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's primary areas of focus include human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, cardiovascular, hematology/oncology and inflammation/respiratory. We have operations in more than 30 countries worldwide, with headquarters in Foster City, California. We continue to add to our existing portfolio of products through our internal discovery and clinical development programs and through a product acquisition and in-licensing strategy.  ... More ...  

Risk Grade

Where does GILD fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?